PB
Peter Blume-Jensen sold $31K of ACRV stock
Peter Blume-Jensen, President and CEO of Acrivon Therapeutics, Inc. (ACRV), sold 14,036 shares of ACRV stock worth $31K, per an SEC Form 4 filed Aug 27, 2026.
It was an open-market sale.
The trade happened on Aug 25, 2026, 2 days before it was made public.
ACRV has moved -33.5% since the trade date, from $2.18 to $1.45 (Nov 13, 2026 close).
- Traded
- Aug 25, 2026
- Disclosed
- Aug 27, 2026
- Filing delay
- 2 days
- Price since
- -33.5%
- Role
- President and CEO
- Source
- SEC Form 4